Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-He Liu

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Colloids and Surfaces. B, Biointerfaces|August 18, 2022
Aptamer-mediated DNA concatemer functionalized magnetic nanoparticles for reversible capture and release of circulating tumor cellsYa-Ting Zhang, Min Dong, Pan-Pan Xu, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2012
Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5Guisheng Zhou, Shi-He Liu, Kelly M Shahi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical and laboratory study of a complex translocation t (6; 21; 8) (p22; q22; q22) in two patients with acute myeloid leukemia]Jin-ying Gong, Xu-ping Liu, Cheng-wen Li, et al.
World Journal of Surgery|January 21, 2011
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 functionGuisheng Zhou, Marie-Claude Gingras, Shi-He Liu, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|July 19, 2006
Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromesHua-Quan Wang, Zong-Hong Shao, Jun Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 31, 2006
[The prognostic value of quantitative chromosomal abnormality in myelodysplastic syndromes]Hua-quan Wang, Zong-hong Shao, Yan-ran Cao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 31, 2005
[Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes and its implications]Hua-Quan Wang, Zong-Hong Shao, Jun Shi, et al.
Plos One|August 21, 2012
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platformShi-He Liu, Donald D Rao, John Nemunaitis, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Colloids and Surfaces. B, Biointerfaces|August 18, 2022
Aptamer-mediated DNA concatemer functionalized magnetic nanoparticles for reversible capture and release of circulating tumor cellsYa-Ting Zhang, Min Dong, Pan-Pan Xu, et al.
Molecular Endocrinology (Baltimore, Md.)|June 7, 2012
Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5Guisheng Zhou, Shi-He Liu, Kelly M Shahi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical and laboratory study of a complex translocation t (6; 21; 8) (p22; q22; q22) in two patients with acute myeloid leukemia]Jin-ying Gong, Xu-ping Liu, Cheng-wen Li, et al.
World Journal of Surgery|January 21, 2011
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 functionGuisheng Zhou, Marie-Claude Gingras, Shi-He Liu, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|July 19, 2006
Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromesHua-Quan Wang, Zong-Hong Shao, Jun Shi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 31, 2006
[The prognostic value of quantitative chromosomal abnormality in myelodysplastic syndromes]Hua-quan Wang, Zong-hong Shao, Yan-ran Cao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 31, 2005
[Study on the burden of abnormal hematopoietic clone of the patients with myelodysplastic syndromes and its implications]Hua-Quan Wang, Zong-Hong Shao, Jun Shi, et al.
Plos One|August 21, 2012
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platformShi-He Liu, Donald D Rao, John Nemunaitis, et al.
Pageof 6